USANA Health (USJ) Q2 2026 Earnings Report

The call balanced clear strategic progress (strong balance sheet, stable core nutrition, successful new product launches, and retail expansion for Hiya and Rise) with meaningful near-term operational and financial headwinds (a $29M goodwill impairment for Hiya, a quarterly pre-tax loss with a $9M tax charge, lowered full-year outlook, Hiya DTC marketing pressures, and a Rise packaging disruption). Management emphasized long-term conviction and the ability to invest, but acknowledged near-term impacts to revenue, margins, and tax rates.

Management lowered its fiscal 2026 outlook — citing a tougher direct‑to‑consumer digital marketing environment for Hiya and a packaging disruption at Rise Wellness — and now expects Hiya full‑year net sales to be lower than previously anticipated and near‑term net sales at Rise to be reduced; the quarter included a preliminary non‑cash goodwill impairment charge of $29.0 million related to Hiya and a $9.0 million income tax expense on a $19.0 million pre‑tax loss, management said the update reflects roughly a $30–40 million top‑line swing versus prior expectations with about $4–5 million of margin pressure, and they noted an elevated tax rate for the back half of the year despite a strong balance sheet of $169.0 million in cash, zero debt, $20.0 million of free cash flow this quarter, Hiya’s historical advertising spend of about $150.0 million, and Rise’s planned retail footprint of over 4,000 doors by year‑end.